Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis.
Saved in:
| Title: | Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis. |
|---|---|
| Authors: | Chai S; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China., Zhang R; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China., Zhang Y; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China., Carr RD; Hatter Cardiovascular Institute, University College London, UK and Ulster University, Coleraine, United Kingdom., Zheng Y; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China., Rajpathak S; Merck Research Laboratories, Merck & Co., Inc., Rahway, NJ, United States., Ji L; Department of Endocrinology, People's Hospital of Peking University, Beijing, China. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Oct 12; Vol. 13, pp. 994944. Date of Electronic Publication: 2022 Oct 12 (Print Publication: 2022). |
| Publication Type: | Meta-Analysis; Systematic Review; Research Support, Non-U.S. Gov't; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2022.994944 |
